Research programme: stem cell therapies - Creative Medical Health

Drug Profile

Research programme: stem cell therapies - Creative Medical Health

Latest Information Update: 02 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator MediStem Laboratories; Russian Academy of Sciences
  • Class Stem cell therapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Research Cardiovascular disorders; Diabetes mellitus; Erectile dysfunction; Female sexual dysfunction; Multiple sclerosis; Neurological disorders; Primary ovarian insufficiency; Spinal cord injuries

Most Recent Events

  • 24 Aug 2016 CREATIVE MEDICAL HEALTH has patents pending for Endothelial Progenitor Cells generation technology
  • 24 Aug 2016 Early research in Primary ovarian insufficiency in USA (Parenteral)
  • 22 Apr 2016 Medistem files for patent protection for mesenchymal stem cell-based therapeutics for the treatment of neurological complications in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top